BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2026-01-14
• Last 15 days FTD volume: A$0 M
• Last 3 months FTD volume: A$0.66 M
• Last 12 months FTD volume: A$4.86 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	A$24.58 M	A$0.24 B	🇺🇸 USA
GSK plc GSK	A$48.95 M	A$0.36 B	🇬🇧 UK
Sarepta Therapeutics SRPT	A$3.82 M	A$21.38 M	🇺🇸 USA
Repligen RGEN	A$6.47 M	A$21.79 M	🇺🇸 USA
Novavax NVAX	A$15.56 M	A$63.4 M	🇺🇸 USA
Celldex Therapeutics CLDX	A$6.56 M	A$10.98 M	🇺🇸 USA
NanoViricides NNVC	A$1.32 M	A$4.28 M	🇺🇸 USA
Cel-Sci CVM	N/A	A$0.37 M	🇺🇸 USA
Emergent BioSolutions EBS	A$0.66 M	A$4.47 M	🇺🇸 USA